Formulation and Delivery - Biomolecular

(M0930-01-01) Brain-Targeted Oxytocin Nanoparticles Formulated via Microfluidics for Epilepsy

(W0930-01-01) Targeting TNBC Tumor Using Hypoxia-Responsive Nanoparticles containing Synergistic Drug Combinations

(W0930-01-03) Developing a Platform for Formulation Screening of High Concentration Monoclonal Antibodies (mAbs)

(W0930-01-05) Assessment of Phenol and Benzyl Alcohol for Use as Preservatives in mAb Drug Therapies

(W0930-01-06) Intranasal Delivery of pApoE to the Brain for Developing Effective Therapeutics for Alzheimer’s disease

(M0930-02-08) A Novel Immunization Strategy against Malaria Using Microneedles and Virus-Like Particles Vaccine

(M0930-02-09) Combating SARS-CoV-2 Variants: Pain-Free Bivalent Intranasal Vaccination Delivery

(T0930-02-10) Engineered Anti-CD40 Agonist Antibody as a Novel Cancer Neoantigen Vaccines

(W0930-02-10) Evaluation of the Effect of the Backing Layer Formulation on Dissolvable Microneedle Properties

(M0930-02-14) T Lymphocyte Proliferation in Response to Microparticulate Vaccine Candidates against H1N1 Flu and Neisseria gonorrhea Pathogens

(T0930-03-15) In Vivo Confirmation of the Permeation Enhancement Capacity of Labrafac™ MC60

(W0930-03-15) Oral Delivery of Probiotics Using Delayed-Release Capsules: Formulation and Dosage Form Considerations

(M0930-03-16) New Insight into the Oral Delivery Mechanism of Semaglutide Based on All-atom Molecular Dynamics Simulations

(T0930-03-16) Remote Loading of Setmelanotide in Poly(lactic-co-glycolic acid) Microspheres for Long-Term Obesity Control

(M0930-03-51) Boosting Antitumor Immune Response against Breast Cancer Cells Using Doxorubicin and Zinc Oxide Nanoparticles Co-loaded Lipid Nanocarrier

(T0930-11-71) Development of a Novel Tacrolimus Loaded Thermoresponsive Nanoemulgel for Local Immunomodulation in Organ Rejection

(M0930-11-72) Drug-Free Bioresponsive Hydrogel for On-Demand Contraception

(W0930-11-73) Oral Tablets Containing a Model Protein API – Impacts of Excipient Selection, API Loading, Unit Operation, and Manufacturing Process Parameters on Tablet Properties, Performance, and Stability

(T0930-11-74) Microbicide-Containing SMART Gel for Female-Controlled Multipurpose Prevention

(W0930-12-77) An Insight into the Interrelationship between Colloidal Stability of Protein Therapeutics in Formulation and Their Adsorption to a Solid Surface

(T0930-12-77) Bioinspired Nanoerythrocytes for Metabolic Microenvironment Remodeling and Long-Term Prognosis Promoting of Acute Ischemic Stroke

(M0930-12-77) Low Dose Compatibility Testing With and Without Surfactant in Polyethylene Terephthalate (PETG), Glass, and Polypropylene Container Types for Large Molecule Analysis

(M1030-01-01) Breaking the Pain Barrier: Innovative Strategies for Administering a Whole Cell Inactivated Microparticulate Gonorrhea Vaccine

(M1030-01-05) Thrombocytopenia Protective Quetiapine Hemifumarate-Loaded Nasal Nanoemulgels for Schizophrenia

(T1030-02-08) Adjuvanted Ionizable Lipid Nanoparticles for mRNA Delivery

(W1030-02-08) Characterization of In Situ Forming Implants Using CT Imaging

(M1030-02-10) Dual Functionalized Liposomal Nanoparticles Can Deliver Plasmid Encoding for Angiotensin II Receptor shRNA to the Brain of Spontaneously Hypertensive Rats to Reduce Blood Pressure

(W1030-02-10) Evolving Component Technologies to Meet the Needs of Large Volume Injections

(W1030-02-12) Pain-Free Alternatives for Vaccinating against the Zika Virus Using 3D Printed Orally Dissolving Films (ODF) and Intranasal Drops

(W1030-03-15) Controlled Release of TLR7/8 Agonist-Manganese from PLGA Microparticles for Enhanced Cancer Immunotherapy

(T1030-03-15) Expanding the Space of Hydroxyl-Rich Lyoprotectants through High-Throughput Screening to Support the Lyophilization of Yeast-Based Therapeutics

(M1030-11-70) Controlled Release Edaravone Nanosuspension: A Translational Therapeutic Approach for the Prevention of Preterm Birth

(W1030-11-71) Development of Tablets with Biologics: Effect of Freeze-Dried and Spray-Dried Powders on the Compaction Behavior

(M1030-11-72) Guided Assembly of Lymph Node Stromal Cells Using a Biomaterial Formulation

(W1030-11-75) Systemic Coadministration of Selective PDE4B Inhibitor A-33 and the Pan-PPAR Agonist Lanifibranor Ameliorates Chronic Liver Disease

(M1030-12-77) A Study on the Visible Aggregation of a Peptide Formulation Under Stress Conditions at Manufacturing Fill and Finish Process

(W1030-12-77) Application of Machine Learning to the Development of Lipid Nanoparticle

(T1030-12-77) Developing an In Situ Hyaluronic Acid-Tyramine Hydrogel Platform to Deliver Extracellular Vesicles

(T1130-01-01) Acoustic Levitation: A Novel Experimental Tool to Study Drying Kinetics and Particle Formation of Pharmaceutical Excipients

(M1130-01-03) A Clinical Study to Assess the Bioequivalence of Topical Diclofenac Products Using Dermal Open Flow Microperfusion

(W1130-01-04) Biodegradable Nanogels for Controlled Release of Artemisinin-Derived Drug to Treat Leukemia

(W1130-01-05) Fibronectin (FN) Binding Efficacy of PEGylated FUD (PEG-FUD) Peptide in Bleomycin Treated Animal Model for the Treatment of Pulmonary Fibrosis

(M1130-01-05) Toward Enhanced Stability of mRNA Lipid Nanoparticles

(T1130-01-06) Cyclodextrin Modulation of Lanreotide Gel Formation and Diffusional Release from an Emulated Subcutaneous Delivery Device

(M1130-01-07) Map the Formulation Space of Lipid Nanoparticles (LNPs) Using Microfluidic Assembly in the Intraperitoneal (IP) Administration of RNA Therapeutics

(T1130-02-08) An Oleic Acid-Conjugated Vaccine Antigen for Enhanced Physicochemical Properties and Thermal Stability via Self-Assembled Nanonization

(W1130-02-11) Interaction between Different Types of Excipients and Protein

(W1130-02-12) Polydopamine-Coated Nanoparticles as a Targeted Drug Delivery System for the Treatment of Helicobacter pylori-Infected Gastric Ulcer

(T1130-03-15) Albumin corona Improves Colloidal Stability of Nanosac, the Non-cationic Polyphenol Gene Carrier

(W1130-03-15) On-Demand Multi-Indication Fast-Dissolving Inserts (FDIs) for Birth Control and HIV Prevention

(M1130-03-15) Synergistic Chemotherapy for Prostate Cancer Mediated by Brusatol and Docetaxel-Loaded Nanoparticles: Cell Cycle Arrest and Apoptosis Mechanisms

(T1130-03-16) Deaeration Enhances the Cryoprotective Effect of Tween 80 on Denaturation of Bovine IgG during Thin-Film Freezing

(M1130-03-16) Enteric Functional Ready-to-Fill Capsule Solution from Pre-Clinic to Commercial

(T1130-11-71) Predicting the Stability of Lyophilised Protein Mixtures with Terahertz Spectroscopy

(M1130-11-72) Effect of Tetanus Toxoid Fragment C (TT_c) and Transferrin (T_f) Functionalized Liposomal Nanoparticle Encapsulating Plasmid APOE2 for the Treatment of Alzheimer’s Disease

(W1130-11-73) IR-820 Dye-Based Layer-by-Layer Inhalation System as a Theranostic Agent for Non-invasive NIRF Imaging of Tumor Margins in Lung Cancers

(W1130-11-75) Tailoring Ligand-Altered Nanostructured Lipid Carrier for the Brain Delivery of Anti-cancer Drug cum herbal Compound for the Treatment of Glioblastoma Multiforme

(M1130-12-77) Stabilization and Formulation Development of Lipid Nanoparticles (LNPs) for Nucleic Acid-Based Therapeutics

(T1130-12-77) Vitamin D and Insulin Microparticle Incorporation into 3D-Printed Gene-Activated Calcium Phosphate Cement Scaffolds for Bone Regeneration Applications

(T1230-01-02) Immunity for the Long Haul: Exploring Cross-Protectivity against Emerging Strains upon Vaccination with Gonococcal Vaccine Microparticles in Mice

(T1230-02-09) Development and In Vitro Evaluation of Donepezil, Memantine and siRNA Encapsulated Liposomes

(M1230-02-10) Effect of Homotypic vs Heterotypic Interactions on the Cellular Uptake of Extracellular Vesicles

(M1230-02-11) Formulation and Biological Evaluation of Spray Dried Microparticles Loaded with LL37 Antimicrobial Peptide

(W1230-02-11) Intestinal Delivery of Live Biotherapeutic Products by pH-Sustaining Hydrogels and Their Therapeutic Efficacies on DSS-Induced Colitis

(T1230-02-13) Reduction of Blood Pressure in the Spontaneously Hypertensive Rats via the Nose-to-Brain Delivery of Plasmid DNA Encoding for Angiotensin II Receptor shRNA

(T1230-03-15) Controlled Release of Monoclonal Antibodies from Long-Acting PLGA-Coated Implants

(W1230-03-15) Development of Aerosolizable mRNA Incorporated Chitosan Nanoparticles for Efficient Lung Delivery

(M1230-03-15) Fabrication of Eco-Benign Isoniazid-Loaded-Silver Nanoparticles: A Novel Approach against Multidrug-Resistant Tuberculosis

(T1230-03-16) Conjugation Chemistry of Antibody-Liposome Conjugates Affects Performance via Complement Activation and Mechanisms Thereof

(M1230-03-16) Systemic Delivery of Paclitaxel by Find-Me Nanoparticles Activates Anti-tumor Immunity and Eliminates Tumors

(W1230-11-73) Lipid Nanoparticles versus Lipoplexes: Optimizing Complexing Head Group and Formulation Technology for Efficient Gene Delivery

(T1230-11-74) Novel Gene Therapy for Drug-Resistant Melanoma: Synergistic Combination of PTEN Plasmid and BRD4 PROTAC Loaded Lipid Nanocarriers

(W1230-11-74) Predicting Stability of Lyophilized mRNA/LNP Formulations Using Solid State NMR

(W1230-11-75) The Application of Machine Learning in Predicting Bioink Printability

(T1230-12-77) Analytical Characterization for Nucleic Acid Therapy: A Case Study

(M1230-12-77) Cellular Uptake and Real-Time ROS Sensing of Doxorubicin-Loaded Self-Assembled Albumin Nanoparticles Using Liver Bilayer Microfluidic Chip System

(T1330-02-12) Novel Bio-Active Peroxisomal Proliferator Activating Receptor Gamma (PPARγ) Hydrogel for Periodontitis Management

(M1330-03-15) Effect of Atomic Layer Coatings on the Stability of Solid Myoglobin Formulations

(T1330-03-15) Viable Eukaryotic Cell Dry Powders Prepared by Thin Film Freeze-Drying

(M1330-03-16) Mutant mRNA Encapsulated Aptamer Conjugated-Lipid Nanoparticles for Targeting Heart Cells

(T1330-03-16) pRNA Nanoparticles for Ocular Delivery: Pharmacokinetics and Pharmacodynamics After Subconjunctival Injection

(M1330-11-70) A Novel Approach to Formulation Screening of High Concentration Recombinant Human Heparan-N-Sulfatase (rhHNS) Using High-Throughput Devices

(M1330-11-75) Reversible, Covalent DNA Condensation Approach via Chemical Linkers for Enhanced Gene Delivery to Nucleus

(M1330-11-76) Triggering Mucosal Immunity: An Intranasal Combination Vaccine for COVID-19 and Influenza

(T1330-12-77) Delivery of Therapeutic Plant-Derived Exosomes to the Brain for the Treatment of Mental Health Disorders and CNS Injuries

(M1330-12-77) Dual Functionality of Poloxamer 188 in Freeze Dried Protein Formulations: A Stabilizer in Frozen Solution and a Bulking Agent

(M1430-01-01) Drug Loading Efficiency of a Topical Anorectal Wipes: A Wipe Impregnation Study

(T1430-01-01) Osimertinib Immunoliposomes as Inhaled Therapy for Non-small Cell Lung Cancer Treatment

(T1430-01-03) Exploring the Potential of Inhaled Nano Therapy for Malignant Pleural Mesothelioma

(T1430-01-04) Analysis and Simulation of In Vivo Nanoparticle Protein Carrier Pharmacokinetics

(M1430-01-06) Multi-functionalized Cationic Chitosan Polymeric Micelles for pVGF Delivery to the Brain through the Intranasal Route

(M1430-02-08) A Thermosensitive Hydrogel Formulation of Phage and Colistin Combination for Management of Multidrug-Resistant Acinetobacter baumannii Wound Infection

(M1430-02-10) Effects of Monomer on PLGA Based Long-Acting Injectables’ Release and Stability

(T1430-02-10) Evaluating Treatment Efficiency of RV and Kinase Inhibitor (KI) in Combination for Alzheimer’s disease: Cell Line Study

(M1430-03-15) Development of 3D Printable Inks for Protein Delivery

(M1430-03-16) Solubility Enhancement of Atorvastatin Calcium Trihydrate by Melt Extrusion

(T1430-03-16) Temperature Variations and Impurities Preclude a Reliable Measurement of the Diffusion Interaction Parameter for Monoclonal Antibodies

(M1430-11-71) Development and Characterization of RVG9R-Tansferrin Liposomal Nanoparticles Encapsulating Plasmid GFP for Targeted Delivery to the Brain

(M1430-11-73) Impact of Quantitative Differences in an Inactive Ingredient on the Performance of Topical Products Containing Lidocaine or Diclofenac Sodium

(T1430-11-73) Investigating Phase Separation of Trehalose during Lyophilization of Proteins Using Solid State NMR

(M1430-12-77) A Rational and Data-Driven Approach to Formulation of Therapeutic Peptides

(T1430-12-77) Development of a Dual-Drug Conjugate for Site-Specific Delivery to Prostate Cancer

(M1530-01-01) A Promising Peptide-Based Universal Vaccine against MERS-CoV and SARS-CoV2 Coronaviruses

(M1530-01-04) Heat Shock Protein-Loaded Mitochondria Containing Microvesicles Protect the Blood-Brain Barrier in Ischemic Stroke

(M1530-01-05) Nanosac: A Soft Nanocarrier for Systemic siRNA Delivery to Solid Tumors

(M1530-02-08) A Versatile Room Temperature Stable Lipid Nanoparticle COVID-19 Protein-Based Vaccine

(T1530-02-08) BIONDD^TM Oral Capsule Delivery of Liraglutide with Bioavailability Comparable to Subcutaneous Injection and Development of Efficient In Vivo Model in Dogs to Test Feasibility of Other Biologic Drugs

(M1530-02-14) β-catenin Inhibition Using XAV939 Nanoparticle Promotes Immunogenic Cell Death and Suppresses Tumor Progression

(M1530-03-15) Monitoring of Lidocaine Transport through Dermis and Subcutis into Muscle Tissue after Application via Topical Delivery Systems

(M1530-03-16) Robust Rugose Lipid Microparticles for Respiratory Delivery of Biologics

(M1530-11-74) Micellar Codelivery of DQ, a Disulfiram Based Prodrug with In Situ Copper Ions Chelation for Cancer Therapy

(M1530-12-78) Hot and Cold Formulation of Biologics for the Optimization of Drying Technologies